# Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment

> **NCT06523764** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 208 (estimated)

## Conditions studied

- Helicobacter Pylori Infection Chronic Gastrit

## Interventions

- **DRUG:** tegoprazan
- **DRUG:** Minocycline
- **DRUG:** bismuth potassium citrate
- **DRUG:** Esomeprazole 40mg
- **DRUG:** Amoxicillin
- **DRUG:** clarithromycin

## Key facts

- **NCT ID:** NCT06523764
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-11
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06523764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06523764, "Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06523764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*